RadNet (RDNT) Jefferies 2024 Global Healthcare Conference summary

Strategic transformation and business segmentation

• Announced a split into two reporting segments: traditional imaging services and a new digital health division, effective January 1, with the first quarter report reflecting this change.

• Digital health division focuses on artificial intelligence (AI) and generative AI, aiming to transform healthcare and imaging.

• Infrastructure growth continues through tuck-in and larger acquisitions, supported by recent capital raises.

AI innovation and commercialization

• AI tools for breast, lung, and prostate screening are being developed and commercialized, with mammography AI (EBCD) gaining significant traction.

• Over 40% of female patients on the East Coast opt for the self-pay AI mammography tool, indicating strong demand despite lack of reimbursement.

• Lung AI tool is part of a major UK rollout, interpreting 80% of screened cases, with expected quadruple growth in 3-4 years.

• Prostate AI tool (Manogram) shows promise for earlier cancer detection compared to traditional methods.

• Generative AI will be implemented in contact centers and operations by Q3, with full rollout expected by early next year.

Market expansion and partnerships

• Joint ventures with major health systems provide a built-in market for AI tools, with interest in standardizing imaging platforms.

• Collaborations with OEMs aim to integrate AI tools directly into imaging equipment, potentially expanding distribution channels.

• Entered the Texas market and is considering further expansion through acquisitions and joint ventures.